pickabook books with huge discounts for everyone
pickabook books with huge discounts for everyone
Visit our new collection website www.collectionsforschool.co.uk
     
Email: Subscribe to news & offers:
Need assistance? Log In/Register


Item Details
Title: FDA IN THE TWENTY-FIRST CENTURY
THE CHALLENGES OF REGULATING DRUGS AND NEW TECHNOLOGIES
By: I. Glenn Cohen (Editor), Holly Fernandez Lynch (Editor)
Format: Hardback

List price: £62.00
Our price: £49.60
Discount:
20% off
You save: £12.40
ISBN 10: 0231171188
ISBN 13: 9780231171182
Availability: Usually dispatched within 1-3 weeks.
 Delivery rates
Stock: Currently 0 available
Publisher: COLUMBIA UNIVERSITY PRESS
Pub. date: 8 September, 2015
Pages: 568
Description: The collection features essays on effective regulation in an era of globalization, consumer empowerment, and comparative effectiveness, as well as questions of data transparency, conflicts of interest, industry responsibility, and innovation policy, all with an emphasis on pharmaceuticals. Dealing honestly and thoroughly with the FDA's successes and failures, these essays rethink the structure, function, and future of the agency and the effect policy innovations may have on regulatory institutions abroad.
Synopsis: In its decades-long effort to assure the safety, efficacy, and security of medicines and other products, the Food and Drug Administration has struggled with issues of funding, proper associations with industry, and the balance between consumer choice and consumer protection. Today, these challenges are compounded by the pressures of globalization, the introduction of novel technologies, and fast-evolving threats to public health. With essays by leading scholars and government and private-industry experts, FDA in the Twenty-First Century addresses perennial and new problems and the improvements the agency can make to better serve the public good.The collection features essays on effective regulation in an era of globalization, consumer empowerment, and comparative effectiveness, as well as questions of data transparency, conflicts of interest, industry responsibility, and innovation policy, all with an emphasis on pharmaceuticals. The book also intervenes in the debate over off-label drug marketing and the proper role of the FDA before and after a drug goes on the market. Dealing honestly and thoroughly with the FDA's successes and failures, these essays rethink the structure, function, and future of the agency and the effect policy innovations may have on regulatory institutions abroad.
Publication: US
Imprint: Columbia University Press
Returns: Returnable
Some other items by this author:

TOP SELLERS IN THIS CATEGORY
The $100 Startup (Paperback)
Pan Macmillan
Our Price : £8.02
more details
The Daily Stoic (Paperback)
Profile Books Ltd
Our Price : £8.75
more details
The 50th Law (Paperback)
Profile Books Ltd
Our Price : £9.48
more details
Good Strategy/Bad Strategy (Paperback)
Profile Books Ltd
Our Price : £8.75
more details
Deep Work (Paperback)
Little, Brown Book Group
Our Price : £12.40
more details
BROWSE FOR BOOKS IN RELATED CATEGORIES
 ECONOMICS, FINANCE, BUSINESS AND INDUSTRY
 business & management


Information provided by www.pickabook.co.uk
SHOPPING BASKET
  
Your basket is empty
  Total Items: 0
 

NEW
World’s Worst Superheroes GET READY FOR SOME SUPERSIZED FUN!
add to basket





New
No Cheese, Please! A fun picture book for children with food allergies - full of friendship and super-cute characters!Little Mo the mouse is having a birthday party.
add to basket

New
My Brother Is a Superhero Luke is massively annoyed about this, but when Zack is kidnapped by his arch-nemesis, Luke and his friends have only five days to find him and save the world...
add to basket


Picture Book
Animal Actions: Snap Like a Crab
By:
The first title in a new preschool series from Guilherme Karsten.
add to basket